Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Gómez-Vela M, Sabeh EN. Instituto Universitario de Integración en la Comunidad, Facultad de Psicología, Universidad de Sa lamanca. Disponible en: www.usal.es/∼inico/investigacion/invesinico/calidad.htm 2002
[2.]
V. Calman.
Definitions and dimensions of quality of life.
The quality of life on cancer patients,
[3.]
S. Shumaker, M. Naughton.
The international Assessment of Health –Related Quality of Life: a theoretical perspective.
The international assessment of health-related quality of life: theory, translation, measurement and analysis,
[4.]
H. Schipper, J.J. Clinch, C.L.M. Olweny.
Quality of life studies: Definitions and conceptual issues.
Quality of life and pharmacoeconomics in clinical trials, 2.ª ed., pp. 11-23
[5.]
X. Badía.
Qué es y cómo se mide la calidad de vida relacionada con la salud.
Gastroenterol Hepatol, 27 (2004), pp. 2-6
[6.]
J. Dent, H.B. El-Serag, M.A. Wallander, S. Johansson.
Epidemiology of gastro-oesophageal reflux disease: a systematic review.
Gut, 54 (2005), pp. 710-717
[7.]
M. Díaz-Rubio, C. Moreno-Elola-Olaso, E. Rey, G.R. Locke 3rd, F. Rodríguez-Artalejo.
Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population.
Aliment Pharmacol Ther, 19 (2004), pp. 95-105
[8.]
J. Ponce, O. Vegazo, B. Beltran, J. Jiménez, J. Zapardiel, D. Calle, J.M. Piqué, Iberge Study Group.
Prevalence of gastro-oesophageal reflux disease in Spain and associated factors.
Aliment Pharmacol Ther, 23 (2006), pp. 175-184
[9.]
J. Ronkainen, P. Aro, T. Storskrubb, S.E. Johansson, T. Lind, E. Bolling-Sternevald, et al.
High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report.
Scand J Gastroenterol, 40 (2005), pp. 275-285
[10.]
H.B. El-Serag.
Time trends of gastroesophageal reflux disease: a systematic review.
Clin Gastroenterol Hepatol, 5 (2007), pp. 17-26
[11.]
T. Lind, T. Havelund, R. Carlsson, G. Eriksson, H. Glise, O. Junghard, et al.
The effect of omeprazole (OME) 20 mg and 10 mg daily on heartburn in patients with endoscopy negative reflux disease (ERND) treated on an on-demand basis.
Gastroenterology, 110 (1996), pp. 178A
[12.]
H. Glise, I. Wiklund.
Measurement of the impact of heartburn and dyspepsia on quality of life.
Aliment Pharmacol Ther, 11 (1997), pp. 73-77
[13.]
P. Wahlqvist.
Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life.
Am J Gastroenterol, 96 (2001), pp. 57-61
[14.]
I. Wiklund.
Quality of life in patients with gastroesophageal reflux disease.
Am J Gastroenterol, 96 (2001), pp. 46-53
[15.]
National Heartburn Alliance Survey results 2000: a community perspective Disponible en: www.heartburnalliance.org/survey 2000.
[16.]
AGA.
Understanding Heartburn in America.
Gallup Or ganization for American Gastroenterological Association, (2000),
[17.]
K. Jasani, L. Piterman, L. McCall.
Gastroesophageal reflux and quality of life. Patient's knowledge, attitudes and perceptions.
Aust Fam Physician, 28 (1999), pp. 15-18
[18.]
M. Kulig, A. Leodolter, M. Vieth, E. Schulte, D. Jaspersen, J. Labenz, et al.
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease: an analysis based on the ProGERD initiative.
Aliment Pharmacol Ther, 18 (2003), pp. 767-776
[19.]
E.M. Quigley, A.P. Hungin.
Review article: quality-of-life issues in gastro-oesophageal reflux disease.
Aliment Pharmacol Ther, 22 (2005), pp. 41-47
[20.]
A.J.P.M. Smout.
Endoscopy-negative acid reflux disease.
Aliment Pharmacol Ther, 11 (1997), pp. 81-85
[21.]
M.A. Eloubeidi, D. Provenzale.
Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.
Am J Gastroenterol, 95 (2000), pp. 1881-1887
[22.]
K. Lauritsen.
Management of endoscopy-negative reflux disease: progress with short-term treatment.
Aliment Pharmacol Ther, 11 (1997), pp. 87-92
[23.]
I. Wiklund, K.D. Bardhan, S. Müller-Lissner, M.A. Bigard, G. Bianchi Porro, J. Ponce, et al.
Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial.
Ital J Gastroenterol Hepatol, 30 (1998), pp. 19-27
[24.]
T.L. Venables, R.D. Newland, A.C. Patel, J. Hole, M.B. Copeman, M.L. Turbitt.
Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice.
Scand J Gastroenterol, 32 (1997), pp. 627-632
[25.]
T. Lind, T. Havelund, S.A. Pedersen, H. Glise, L. Lundell, R. Carlsson, et al.
On demand treatment with omeprazole (OME) maintains quality of life (QOL) during long-term follow-up of patients with endoscopy negative reflux disease (ENRD).
Gastroenterology, 110 (1996), pp. 178A
[26.]
D. Korolija, S. Sauerland, S. Wood-Dauphinée, C.C. Abbou, E. Eypasch, M.G. Caballero, European Association for Endoscopic Surgery, et al.
Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery.
Surg Endosc, 18 (2004), pp. 879-897
Copyright © 2008. Elsevier España S.L.. Todos los derechos reservados
